Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics

<p>Includes the list of peptides derived from NSM identified at 0.02 FDR and ALC>=30</p>

Uloženo v:

Podrobná bibliografie
Hlavní autor:	Maria Lozano-Rabella (15056515) (author)
Další autoři:	Andrea Garcia-Garijo (15056518) (author), Jara Palomero (15056521) (author), Anna Yuste-Estevanez (15056524) (author), Florian Erhard (15056527) (author), Roc Farriol-Duran (15056530) (author), Juan Martín-Liberal (15056533) (author), Maria Ochoa-de-Olza (15056536) (author), Ignacio Matos (15056539) (author), Jared J. Gartner (15046103) (author), Michael Ghosh (15056542) (author), Francesc Canals (15056545) (author), August Vidal (15056548) (author), Josep Maria Piulats (15056551) (author), Xavier Matías-Guiu (15056554) (author), Irene Brana (15056557) (author), Eva Muñoz-Couselo (14957498) (author), Elena Garralda (15039090) (author), Andreas Schlosser (15056560) (author), Alena Gros (15056563) (author)
Vydáno:	2025
Témata:	Cancer Therapeutic Research and Development Immuno-oncology Immunology Immune responses to cancer Tumor antigens/neoantigens Immunotherapy Cancer vaccines Cellular immunotherapy Translational Research
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky